FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
about
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersGenetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasisFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma.Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.Gene variants in the angiogenesis pathway and prostate cancer.High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal CarcinomaCo-clustering phenome-genome for phenotype classification and disease gene discovery.A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.FGFR4 and TGF-β1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis.Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumorsTargeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy.Fibroblast growth factors and their receptors in cancer.Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells.FGFR4 polymorphic variants modulate phenotypic features of Cushing disease.FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.
P2860
Q26998955-62546B4A-C246-4E73-AB5E-8E08967B28D4Q33461922-F0976EDC-7216-4DBC-9FFE-8877E760B9C6Q33648854-21AB0388-30B0-4A37-BA61-6ED7518E8EBDQ33751398-9C743318-8D00-49E3-9BDF-9B288345EF4BQ33757125-A7A315D3-82CA-4BCB-B208-C77F836B3CD8Q33783047-34EF5506-30C0-4DF4-AA4F-D33E32B8224BQ34505851-B11E710D-7114-4647-9E9A-ED2B1AA8A1FFQ35324807-1D65458D-6E82-4CD9-B65D-96BD8512C365Q35959897-956E3FDB-3C85-436E-8F90-4B7F2E25E1DEQ36059811-3B008D62-57AE-42DB-BCA0-50825CBA7B44Q36118876-CF5F9931-8264-4651-B98A-B998CDEE9A8AQ36214131-FD5E9C1F-DF34-4033-A907-020A8EE931B2Q36341451-53435DE0-1585-4BCF-926C-7563F4417383Q36594039-0EBB2486-056E-49B9-9AA4-3054290A7BEFQ36612496-00641DE8-BB0D-44F1-80D6-4AA2E942B00CQ36787646-6365884C-6A42-4FD5-B016-AE2839CDB523Q37002454-05E67BEE-55F2-499F-88D2-AA8F6870BA14Q37050510-7288869E-6528-4F8B-A261-E21F64585B7BQ37264491-61638676-0955-45F6-B3D4-F6B4E48EBCD2Q37288883-C58B1566-D608-4794-84F2-659105CA5746Q37376265-7227FCA5-9AC6-4DC6-9A36-094641D4CD35Q37620612-7083EC28-081C-4123-A314-7D1862331DE9Q37709494-0B65B9F6-0736-4946-BF42-43275A26302DQ37849781-9DB6ADAF-8BA6-45C0-8454-A47AEB119D4BQ37895306-9E1EF61B-683A-4AA9-9612-3DDC2FAFE3A9Q38186064-CD9D6505-B8D2-4C1D-8B47-FA2A377EC0FEQ38212165-A508C180-A226-41AC-90AD-50485B11EB95Q38811286-8D41D79B-58E7-466E-A031-674865B01631Q39534119-5E32D378-ADD8-4714-8AC0-9F836DEC116AQ39769519-F1299CB1-A7BF-4B94-A51B-F97F9E8A2721Q42056698-1EC82E55-662E-4352-B1F7-5FD3A0AB76B7Q43165954-6615A4A5-3979-4981-9D5F-816343F1A889Q48169062-44EC719C-ABBD-4855-923A-6CD211008CFDQ49306280-49F70564-2AAC-48E6-A786-FADCE44828B0Q54171446-FED1363B-4191-4024-96F1-B535E9A3799C
P2860
FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@ast
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@en
type
label
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@ast
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@en
prefLabel
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@ast
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@en
P2093
P2860
P356
P1476
FGFR4 Arg388 allele correlates ...... survival of melanoma patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603181
P407
P577
2006-05-23T00:00:00Z